Please assess the completion status of the following clinical trial:

Trial Title: Continuous Nerve Block Block vs Combination of Single Block Plus Intravenous Lidocaine for Postoperative Pain.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18-90 years old~* Primary unilateral VATS or major abdominal surgery~* BMI 20-36, weight ≥ 50kg~* Male and Female~* All races~Exclusion Criteria:~* Patient refusal~* Inpatient status at the time of surgery~* ASA class 4 or greater~* Pregnancy~* Non-English speaking or inability to participate in the study~* Patients with coagulopathy or on therapeutic anticoagulation~* Chronic steroid use~* Opioid use disorder~* Contraindication to performing any of the proposed blocks - active infection at the block site, systemic infection, allergy to local anesthetic medications~* Patients undergoing second surgery or urgent/emergent surgery~* Patients weighing \< 50kg~* History of chronic pain and/or opioid tolerant~* Anticipated requirement for patient-controlled analgesia (PCA)~* Allergy or intolerance to any medication specified in the study protocol or postoperative pain management regimen~* Liver disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Continuous nerve blocks (Type: ACTIVE_COMPARATOR): A total of 30 subjects equally distributed to either continuous Erector Spinae Plane block for unilateral thoracic surgery , or continuous Quadratus Lumborum block for major abdominal surgery. Patients in this group will receive 20ml 0.5% ropivacaine per block performed after positioning of the needle followed by continuous perineural infusion of 0.25% lidocaine (10ml/hr) beginning in the post-anesthesia care unit (PACU) and continued for 72 hours or until 12 hours prior to patient discharge, whichever comes first, which is standard of care at this institution.
- Single nerve blocks plus IV lidocaine infusion (Type: EXPERIMENTAL): A total of 30 subjects equally distributed to either Erector Spinae Plane block for unilateral thoracic surgery, or Quadratus Lumborum block for major abdominal surgery, will be included . Patients in this group will receive 20ml 0.5% ropivacaine, 4mg dexamethasone, and 20mcg dexmedetomidine (30mcg if only one block is performed) per block after proper positioning of the Tuohy needle. Upon patient arrival in the recovery room a continuous infusion of IV lidocaine 50 mg /hr will be started and continued for 72 hours or until 12 hours prior to patient discharge, whichever comes first, which is standard of care at this institution.

Based on this trial design, predict the completion outcome and termination type (if applicable).